An Open Label Investigational Immuno-therapy Trial of Nivolumab in Cancers That Are Advanced or Have Spread
Public ClinicalTrials.gov record NCT02832167. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open Label Phase 2 Multi-cohort Trial of Nivolumab in Advanced or Metastatic Malignancies
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether nivolumab is an effective treatment for cancer that has advanced or has spread. Various tumor types may be eligible for enrollment.
Study identification
- NCT ID
- NCT02832167
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 239 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 22, 2016 (Actual)
- Primary completion
- Oct 20, 2019 (Actual)
- Completion
- Jun 24, 2021 (Actual)
- Last update posted
- May 9, 2022
2016 – 2021
United States locations
- U.S. sites
- 39
- U.S. states
- 18
- U.S. cities
- 38
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arizona Oncology Associates, PC | Tucson | Arizona | 85711 | — |
| CBCC Global Research, Inc. at Comprehensive Blood and Cancer Center | Bakersfield | California | 93309 | — |
| St. Jude Hospital Yorba Linda | Fullerton | California | 92835 | — |
| LACN | Los Angeles | California | 90017 | — |
| UCLA Main Campus - University California Los Angeles | Los Angeles | California | 90095 | — |
| Torrence Health Association, DBA Torrance Memorial;Physician Network/Cancer Care Associates | Redondo Beach | California | 90277 | — |
| Coastal Integrative Cancer Care | San Luis Obispo | California | 93401 | — |
| Cancer Center of Santa Barbara with Sansum Clinic | Santa Barbara | California | 93105 | — |
| Central Coast Medical Oncology Corporation | Santa Maria | California | 93454 | — |
| Rocky Mountain Cancer Centers - Denver Midtwon | Denver | Colorado | 80218 | — |
| St. Mary's Hospital And Regional Medical Center | Grand Junction | Colorado | 81501 | — |
| Memorial Healthcare System | Hollywood | Florida | 33021 | — |
| Florida Cancer Affiliates | Ocala | Florida | 34471 | — |
| Orlando Health, Inc | Orlando | Florida | 32806 | — |
| Florida Cancer Specialists & Research Institute | St. Petersburg | Florida | 33705 | — |
| Florida Cancer Specialists | West Palm Beach | Florida | 33401 | — |
| Illinois Cancer Specialists | Niles | Illinois | 60714 | — |
| Fort Wayne Medical Oncology and Hematology, Inc. | Fort Wayne | Indiana | 46845 | — |
| Maryland Oncology Hematology P.A. | Columbia | Maryland | 21044 | — |
| Minnesota Oncology Hematology, P.A. | Minneapolis | Minnesota | 55404 | — |
| HCA Midwest Healthcare | Kansas City | Missouri | 64132 | — |
| Oncology Hematology West P.C. dba Nebraska Cancer Specialists | Omaha | Nebraska | 68130 | — |
| Texas Oncology-Austin Central | Las Vegas | Nevada | 89148 | — |
| Saint Barnabas Medical Cancer Center | Livingston | New Jersey | 07039 | — |
| USOR - New York Oncology Hematology, P.C. | Albany | New York | 12206 | — |
| Hematology Oncology Associates, PC | Medford | Oregon | 97504 | — |
| Willamette Valley Cancer Institute and Research Center | Springfield | Oregon | 97477 | — |
| Northwest Cancer Specialists, P.C. | Tualatin | Oregon | 97062 | — |
| Greenville Health System | Greenville | South Carolina | 29615 | — |
| West Cancer Center | Germantown | Tennessee | 38138 | — |
| Tennessee Oncology | Lebanon | Tennessee | 37090 | — |
| Texas Oncology - Baylor Charles A. Simmons Cancer Center | Dallas | Texas | 75246 | — |
| Texas Oncology, P.A. | Fort Worth | Texas | 76104 | — |
| The University of Texas MD Anderson Cancer Center-merge | Houston | Texas | 77030 | — |
| Texas Oncology, P.A. | San Antonio | Texas | 78240 | — |
| Texas Oncology The Woodlands | The Woodlands | Texas | 77380 | — |
| Texas Oncology - Waco | Waco | Texas | 76712 | — |
| Virginia Cancer Care Specialist, PC | Fairfax | Virginia | 22031 | — |
| Oncology and Hematology Associates of Southwest Virginia, Inc., DBA Blue Ridge Cancer Care | Wytheville | Virginia | 24382 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 6 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02832167, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 9, 2022 · Synced Oct 30, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02832167 live on ClinicalTrials.gov.